search
Back to results

Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis

Primary Purpose

Chronic Sinusitis, Ethmoidal, Chronic Sinusitis - Ethmoidal Anterior, Chronic Sinusitis

Status
Unknown status
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
gel loaded with steroids (momentasone)
gel loaded with antibiotic (Levofloxacin)
gel loaded with both steroids and antibiotic
Sponsored by
LifeBridge Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Chronic Sinusitis, Ethmoidal

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Chronic sinusitis symptoms with or without polyps
  2. Trial of at least 2 courses of oral antimicrobial treatment without significant improvement
  3. CAT scan showing evidence of bilateral symmetric chronic sinusitis with or without polypss
  4. Endoscopic confirmation of CRS

Exclusion Criteria:

  1. Minor (Less than <18 years of age).
  2. Pregnant and breastfeeding women.
  3. Allergy to specific antibiotics
  4. Patient currently taking oral corticosteroids.
  5. Patient currently taking oral antibiotics.

Sites / Locations

  • Sinai Hospital of BaltimoreRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm 10

Arm 11

Arm 12

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

CRSwNP - Subgrp 1(Momentasone - Right)

CRSwNP-Subgrp 2(Levofloxacin - Right)

CRSwNP-Subgrp 3(Steroid/Antibotic Right)

CRSsNP - Subgrp 1 (Momentasone Right)

CRSsNP - Subgrp 2 (Levofloxacin Right)

CRSsNP-Subgrp 3(Steroid/Antibiotic Right

CRSwNP - Subgrp 1 (Momentasone Left)

CRSwNP - Subgrp 2 (Levofloxacin Left)

CRSwNP-Subgrp 3(Steroid/Antibiotic Left)

CRSsNP - Subgrp 1 (Momentasone Left)

CRSsNP - Subgrp 2 (Levofloxacin Left)

CRSsNP-Subgrp 3(Steroid/Antibiotic Left)

Arm Description

Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only on right side and placebo on left side

Patients undergoing balloon sinuplasty with receive a gel loaded with antibiotic (Levofloxacin) only on right side and placebo on left side

Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on right side and placebo on left side

Patients undergoing ballon sinuplasty will receive a gel loaded with steroids (Momentasone) only on right side and placebo on left side

Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only on right side and placebo on left side

Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on right side and placebo on left side

Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only on left side and placebo on right side

Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only left side and placebo on right side

Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on left side and placebo on right side

Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only left side and placebo on right side

Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only left side and placebo on right side

Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on left side and placebo on right side

Outcomes

Primary Outcome Measures

Clinical improvement reported on SNOT-22 questionnaire
Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day.
Improvement in the Lund-Kennedy endoscopic appearance scores. Improvement in the Lund-Kennedy endoscopic appearance scores
Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day. Polyps (left, right) Edema (left, right) Discharge (left, right) Scarring (left, right) Crusting (left, right) Scoring: Polyps on left side - (0 absent, 1 polyps in middle meatus, 2 polyps beyond middle meatus) Polyps on right side - (0 absent, 1 polyps in middle meatus, 2 polyps beyond middle meatus) Edema, scarring and crusting on left side (0 absent, 1 mild, 2 severe) Edema, scarring and crusting on right side (0 absent, 1 mild, 2 severe) Discharge on left side (0, no discharge, 1 clear, thin discharge, 2 thick purulent discharge) Discharge on right side (0, no discharge, 1 clear, thin discharge, 2 thick purulent discharge)

Secondary Outcome Measures

Radiological improvement of the Lund-Mackay score
Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day. Paranasal sinuses Right Left Maxillary (0, 1, 2) Anterior Ethmoid (0, 1, 2) Posterior Ethmoid (0, 1, 2) Sphenoid (0, 1, 2) Frontal (0, 1, 2) Ostiomeatal complex (0, 2) Total Note: 0- without abnormalities; 1- partial opacification; 2-total opacification 0-no obstruction; 2-obstructed

Full Information

First Posted
December 15, 2017
Last Updated
March 13, 2018
Sponsor
LifeBridge Health
search

1. Study Identification

Unique Protocol Identification Number
NCT03472144
Brief Title
Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis
Official Title
Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Unknown status
Study Start Date
July 7, 2017 (Actual)
Primary Completion Date
July 7, 2019 (Anticipated)
Study Completion Date
December 7, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
LifeBridge Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To assess the efficacy of intra-sinus installation of a poloxamer gel that releases antibiotics and corticosteroids topically after balloon sinuplasty in chronic sinusitis patients with or without polyps. This is a single-blinded Randomized Control Trial study, in which every patient receives active gel on one side and placebo on the other (L or R to be randomly selected).
Detailed Description
STUDY DESIGN This is a single-blinded Randomized Control Trial study, in which every patient receives active gel on one side and placebo on the other (L or R to be randomly selected). Sixty patients will be included in this study. These are patients undergoing balloon sinuplasty for Chronic sinusitis with and without polyps. As the patients will enter the study- they will be divided into Chronic sinusitis with Polyps (CRSwNP) and Chronic rhinosinusitis without polyps (CRSsNP). Each patient will be assigned in chronological order as they will join the study. For each group, all even numbered patients will receive the active gel application on right side and all odd number patients will receive the active gel on left side. Then patient selection for CRSwNP and CRSsNP will be as such Each group will have 3 subgroups. Subgroup 1- gel will be loaded with steroids only Subgroup 2- gel will be loaded with antibiotic (Levaquin) only Subgroup 3- gel will be loaded with both steroids and antibiotic CRSwNP group with right side gel application Subgroup 1- patient number- 1,7,13,19,25 Subgroup 2- patient number- 3,9,15,21,27 Subgroup 3- patient number- 5,11,17,23,29 CRSwNP group with left side gel application Subgroup 1- patient number- 2,8,14,20,26 Subgroup 2- patient number- 4,10,16,22,28 Subgroup 3- patient number- 6,12,18,24,30 A similar patient randomization will be done with the CRSsNP group Surgery will consist of plain balloon sinuplasty or hybrid balloon sinuplasty with removal of ethmoids polypss using a Blakesley forceps. During surgery, and immediately after removal of diseased mucosa, 5 ccs of an active poloxamer gel containing the antibiotic or corticosteroids or both will be instilled inside the ethmoid/ maxillary sinus/frontal cavities on one side using either the balloon catheter or as a curved suction tip. The same procedure is performed in the other side, this time with instillation of plain gel without antibiotic or corticosteroids (placebo). The purpose of the study is to assess the efficacy of intra-sinus installation of a poloxamer gel that releases antibiotics and corticosteroids topically after balloon sinuplasty in chronic sinusitis patients with or without polyps. The assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Sinusitis, Ethmoidal, Chronic Sinusitis - Ethmoidal Anterior, Chronic Sinusitis, Chronic Sinusitis - Ethmoidal, Posterior, Chronic Sinusitis, Sphenoidal, Chronic Sinusitis - Frontoethmoidal, Nasal Polyps, Nasal Polyp - Posterior

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
This is a single-blinded Randomized Control Trial study, in which every patient receives active gel on one side and placebo on the other (L or R to be randomly selected).
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Principle investigator will be non blinded and all others will be blinded
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CRSwNP - Subgrp 1(Momentasone - Right)
Arm Type
Experimental
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only on right side and placebo on left side
Arm Title
CRSwNP-Subgrp 2(Levofloxacin - Right)
Arm Type
Experimental
Arm Description
Patients undergoing balloon sinuplasty with receive a gel loaded with antibiotic (Levofloxacin) only on right side and placebo on left side
Arm Title
CRSwNP-Subgrp 3(Steroid/Antibotic Right)
Arm Type
Experimental
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on right side and placebo on left side
Arm Title
CRSsNP - Subgrp 1 (Momentasone Right)
Arm Type
Experimental
Arm Description
Patients undergoing ballon sinuplasty will receive a gel loaded with steroids (Momentasone) only on right side and placebo on left side
Arm Title
CRSsNP - Subgrp 2 (Levofloxacin Right)
Arm Type
Experimental
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only on right side and placebo on left side
Arm Title
CRSsNP-Subgrp 3(Steroid/Antibiotic Right
Arm Type
Experimental
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on right side and placebo on left side
Arm Title
CRSwNP - Subgrp 1 (Momentasone Left)
Arm Type
Active Comparator
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only on left side and placebo on right side
Arm Title
CRSwNP - Subgrp 2 (Levofloxacin Left)
Arm Type
Active Comparator
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only left side and placebo on right side
Arm Title
CRSwNP-Subgrp 3(Steroid/Antibiotic Left)
Arm Type
Active Comparator
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on left side and placebo on right side
Arm Title
CRSsNP - Subgrp 1 (Momentasone Left)
Arm Type
Active Comparator
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only left side and placebo on right side
Arm Title
CRSsNP - Subgrp 2 (Levofloxacin Left)
Arm Type
Active Comparator
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only left side and placebo on right side
Arm Title
CRSsNP-Subgrp 3(Steroid/Antibiotic Left)
Arm Type
Active Comparator
Arm Description
Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on left side and placebo on right side
Intervention Type
Drug
Intervention Name(s)
gel loaded with steroids (momentasone)
Other Intervention Name(s)
Momentasone
Intervention Description
One of the purpose of this study is to evaluate the efficacy of a gel that actively releases local corticosteroids (momentasone) after balloon sinuplasty for chronic sinusitis patients.
Intervention Type
Drug
Intervention Name(s)
gel loaded with antibiotic (Levofloxacin)
Other Intervention Name(s)
Levofloxacin
Intervention Description
One of the purpose of this study is to evaluate the efficacy of a gel that actively releases local antibiotic(levofloxacin) after balloon sinuplasty for chronic sinusitis patients.
Intervention Type
Drug
Intervention Name(s)
gel loaded with both steroids and antibiotic
Other Intervention Name(s)
Momentasone, Levofloxacin
Intervention Description
One of the purpose of this study is to evaluate the efficacy of a gel that actively releases local both steroids (momentasone)and antibiotic(levofloxacin) after balloon sinuplasty for chronic sinusitis patients.
Primary Outcome Measure Information:
Title
Clinical improvement reported on SNOT-22 questionnaire
Description
Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day.
Time Frame
The total duration of the actual study is 30 months, and the follow up period per patient will 6 months postoperatively.
Title
Improvement in the Lund-Kennedy endoscopic appearance scores. Improvement in the Lund-Kennedy endoscopic appearance scores
Description
Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day. Polyps (left, right) Edema (left, right) Discharge (left, right) Scarring (left, right) Crusting (left, right) Scoring: Polyps on left side - (0 absent, 1 polyps in middle meatus, 2 polyps beyond middle meatus) Polyps on right side - (0 absent, 1 polyps in middle meatus, 2 polyps beyond middle meatus) Edema, scarring and crusting on left side (0 absent, 1 mild, 2 severe) Edema, scarring and crusting on right side (0 absent, 1 mild, 2 severe) Discharge on left side (0, no discharge, 1 clear, thin discharge, 2 thick purulent discharge) Discharge on right side (0, no discharge, 1 clear, thin discharge, 2 thick purulent discharge)
Time Frame
The total duration of the actual study is 30 months, and the follow up period per patient will 6 months postoperatively.
Secondary Outcome Measure Information:
Title
Radiological improvement of the Lund-Mackay score
Description
Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day. Paranasal sinuses Right Left Maxillary (0, 1, 2) Anterior Ethmoid (0, 1, 2) Posterior Ethmoid (0, 1, 2) Sphenoid (0, 1, 2) Frontal (0, 1, 2) Ostiomeatal complex (0, 2) Total Note: 0- without abnormalities; 1- partial opacification; 2-total opacification 0-no obstruction; 2-obstructed
Time Frame
The total duration of the actual study is 30 months, and the follow up period per patient will 6 months postoperatively.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic sinusitis symptoms with or without polyps Trial of at least 2 courses of oral antimicrobial treatment without significant improvement CAT scan showing evidence of bilateral symmetric chronic sinusitis with or without polypss Endoscopic confirmation of CRS Exclusion Criteria: Minor (Less than <18 years of age). Pregnant and breastfeeding women. Allergy to specific antibiotics Patient currently taking oral corticosteroids. Patient currently taking oral antibiotics.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alan H. Shikani, MD
Phone
410-601-6673
Email
ashikani@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alan H. Shikani, MD
Organizational Affiliation
Sinai Hospital of Baltimore
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sinai Hospital of Baltimore
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21215
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alan H Shikani, MD
Phone
410-601-6673
Email
Ashikani@gmail.com
First Name & Middle Initial & Last Name & Degree
Hosai T Hesham, MD
Phone
410-601-6673
Email
hosaihesham@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
undecided so far
Citations:
PubMed Identifier
17761281
Citation
Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D, Haydon RC 3rd, Hudgins PA, Jones S, Krouse HJ, Lee LH, Mahoney MC, Marple BF, Mitchell CJ, Nathan R, Shiffman RN, Smith TL, Witsell DL. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007 Sep;137(3 Suppl):S1-31. doi: 10.1016/j.otohns.2007.06.726.
Results Reference
background
PubMed Identifier
18197013
Citation
Vaughan WC. Review of balloon sinuplasty. Curr Opin Otolaryngol Head Neck Surg. 2008 Feb;16(1):2-9. doi: 10.1097/MOO.0b013e3282f5e955.
Results Reference
background
PubMed Identifier
17903570
Citation
Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg. 2007 Oct;137(4):555-61. doi: 10.1016/j.otohns.2007.02.004.
Results Reference
background
PubMed Identifier
27689094
Citation
Alves DA, Machado D, Melo A, Pereira RF, Severino P, de Hollanda LM, Araujo DR, Lancellotti M. Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria. Biomed Res Int. 2016;2016:9702129. doi: 10.1155/2016/9702129. Epub 2016 Sep 5.
Results Reference
background
PubMed Identifier
24597493
Citation
Li C, Gu J, Mao X, Ao H, Yang X. Preparation of levofloxacin thermo-sensitive gel and clinical application in the treatment of suppurative otitis media. Acta Otolaryngol. 2014 May;134(5):468-74. doi: 10.3109/00016489.2013.878473. Epub 2014 Mar 6.
Results Reference
background
PubMed Identifier
17096184
Citation
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006 Dec;23(12):2709-28. doi: 10.1007/s11095-006-9104-4. Epub 2006 Nov 11.
Results Reference
background
PubMed Identifier
20738346
Citation
Shikani AH, Chahine KA, Alqudah MA. The rhinotopic protocol for chronic refractory rhinosinusitis: how we do it. Clin Otolaryngol. 2010 Aug;35(4):329-32. doi: 10.1111/j.1749-4486.2010.02157.x. No abstract available.
Results Reference
result
PubMed Identifier
24817242
Citation
Shikani AH, Chahine KA, Alqudah MA. Rhinotopic therapy for refractory chronic rhinosinusitis: a study of 20 cases. Ear Nose Throat J. 2014 Apr-May;93(4-5):E48-54.
Results Reference
result
PubMed Identifier
23193904
Citation
Shikani AH, Kourelis K, Rohayem Z, Basaraba RJ, Leid JG. Topical gel therapy for sinonasal polyposis in Samter's triad: preliminary report. Ann Otol Rhinol Laryngol. 2012 Nov;121(11):719-24. doi: 10.1177/000348941212101104.
Results Reference
result

Learn more about this trial

Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis

We'll reach out to this number within 24 hrs